Misty Miller, Pharm.D., BCPS
Prof,Asoc
Pharmacy Clinical & Admin Sci
Phone 405-271-6484 x47029
Office CPB 231
Email misty-miller@ouhsc.edu
Publications & Presentations
- 11. Miller M M. Velpatasvir/sofosbuvir: the first pan-genotypic single tablet regimen for the treatment of hepatitis C virus. AJHP. 2017; 74 : 1054-52
12. Miller M M, Kinney K K, Liedtke M D. Virologic failure of high-dose raltegravir with concomitant rifampin. Infectious Diseases in Clinical Practice. 2017; 25 : 168-70
13. Miller M M, Liedtke M D, Lockhart S M, Rathbun C. The role of dolutegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2015; 8
14. Miller M M, Burton M E, Johnson P N, Miller J L. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014; 71 : 2108-9
15. Liedtke M D, Tomlin C R, Miller M M, Lockhart S M, Rathbun C. Long-term efficacy of raltegravir in the management of HIV infection. Infection and Drug Resistance/Dove Press. 2014; 7 : 73-84
Grants
- 1. Ryan White Title IV Women, Infants, Children, Youth (WICY) and Affected Family Members AIDS Healthcare. HHS. Start Date: 2022. End Date: 2023.
2. HIV Adherence Services. State Agency. Start Date: 2021. End Date: 2022.
3. HIV Adherence Services. State Agency. Start Date: 2020. End Date: 2021.
4. Clinical Pharmacy Services. HHS. Start Date: 2020. End Date: 2020.
5. HIV Adherence Services. State Agency. Start Date: 2019. End Date: 2020.
Awards and Honors
no results
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. University of Oklahoma College of Pharmacy/OU Medical Center. Date: 2011.
2. Degree: PGY1 Pharmacy Residency. University of Oklahoma College of Pharmacy/OU Medical Center. Date: 2010.
3. Degree: PharmD. University of Oklahoma College of Pharmacy. Date: 2009.
Administrative Assignments
no results